中国神经再生研究(英文版)

神经退行性病

1.	Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer’s disease (2022-06-17)
2.	DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson’s disease (2022-06-17)
3.	Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer’s disease (2022-06-17)
4.	Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice (2022-06-17)
5.	Dysregulated expression and distribution of Kif5α in neurites of wobbler motor neurons (2022-06-17)
6.	Aquaporin 4 deficiency eliminates the beneficial effects of voluntary exercise in a mouse model of Alzheimer’s disease (2022-03-10)
7.	Abnormal characterization of dynamic functional connectivity in Alzheimer’s disease (2022-03-10)
8.	Endocannabinoid metabolism and Alzheimer’s disease (2022-03-10)
9.	Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet (2022-03-10)
10.	The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer’s disease (2022-03-10)
11.	Perspective on the relationship between microbiota dysbiosis and neuroinflammation: probiotics as a treatment option (2022-03-10)
12.	Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis? (2022-03-10)
13.	Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer’s disease (2022-03-10)
14.	Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease (2022-03-10)
15.	Intranasal neprilysin rapidly eliminates amyloid-beta plaques, but causes plaque compensations: the explanation why the amyloid-beta cascade may fail? (2022-03-10)
16.	Phosphoinositide-3-kinase regulatory subunit 4 participates in the occurrence and development of amyotrophic lateral sclerosis by regulating autophagy (2022-01-12)
17.	Propagation of TDP-43 proteinopathy in neurodegenerative disorders (2022-01-12)
18.	Vibrotactile coordinated reset stimulation for the treatment of Parkinson’s disease (2022-01-12)
19.	Impact of alpha-synuclein pathology on adult neurogenesis: evidence for multilayered mechanisms (2022-01-12)
20.	Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson’s disease? A discussion of data from the culture dish to the clinic (2022-01-12)
21.	All roads lead to Rome — a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer’s disease (2021-12-17)
22.	Liposome based drug delivery as a potential treatment option for Alzheimer’s disease (2021-12-17)
23.	Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study (2021-12-09)
24.	HOXA11-AS aggravates microglia-induced neuroinflammation after traumatic brain injury (2021-12-09)
25.	Brief electrical nerve stimulation enhances intrinsic repair capacity of the focally demyelinated central nervous system (2021-12-08)
26.	Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer’s disease (2021-12-08)
27.	Significance of intercellular communication for neurodegenerative diseases (2021-12-08)
28.	Deuterated dextromethorphan/quinidine for agitation in Alzheimer’s disease (2021-12-08)
29.	Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement (2021-12-08)
30.	Preliminary examination of early neuroconnectivity features in the R6/1 mouse model of Huntington’s disease by ultra-high field diffusion MRI (2021-11-22)
31.	Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer’s disease models (2021-11-22)
32.	From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson’s disease? (2021-11-22)
33.	The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson’s disease (2021-10-19)
34.	HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson’s disease cell and mouse models (2021-10-19)
35.	Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis (2021-10-18)
36.	Striatal oxidative damages and neuroinflammation correlate with progression and survival of Lewy body and Alzheimer diseases (2021-10-18)
37.	Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced nigrostriatal neurodegeneration (2021-10-18)
38.	Brain ischemia as a bridge to Alzheimer’s disease (2021-10-18)
39.	A simple human cell model for TAU trafficking and tauopathy-related TAU pathology (2021-10-18)
40.	Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine (2021-10-18)

跳至
页
第1页
共6页
共206条记录